88 related articles for article (PubMed ID: 8571740)
1. [A relationship between the breakpoint of the bcr gene and some hematologic parameters in patients with chronic myelogenous leukemia].
Seferyńska I; Brojer E; Sankowska M; Majewski M; Maj S
Acta Haematol Pol; 1995; 26(4):385-91. PubMed ID: 8571740
[TBL] [Abstract][Full Text] [Related]
2. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
3. Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia.
Adler R; Viehmann S; Kuhlisch E; Martiniak Y; Röttgers S; Harbott J; Suttorp M
Eur J Haematol; 2009 Feb; 82(2):112-8. PubMed ID: 19067742
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
Mundhada S; Luthra R; Cano P
BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
[TBL] [Abstract][Full Text] [Related]
5. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of chronic myeloid leukemia in eastern India.
Mondal BC; Bandyopadhyay A; Majumdar S; Mukhopadhyay A; Chandra S; Chaudhuri U; Chakrabarti P; Bhattacharyya S; Dasgupta UB
Am J Hematol; 2006 Nov; 81(11):845-9. PubMed ID: 16888785
[TBL] [Abstract][Full Text] [Related]
7. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and follow-up in chronic myeloid leukemia. Detection and quantification of specific transcripts with the help of reverse transcriptase-polymerase chain reaction].
Osland A; Shammas FV; Heikkilä R
Tidsskr Nor Laegeforen; 1996 Feb; 116(6):726-30. PubMed ID: 8644073
[TBL] [Abstract][Full Text] [Related]
9. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
Goh HG; Hwang JY; Kim SH; Lee YH; Kim YL; Kim DW
Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F
Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622
[TBL] [Abstract][Full Text] [Related]
12. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
[TBL] [Abstract][Full Text] [Related]
13. A case of chronic myelogenous leukemia with e8a2 fusion transcript.
Park IJ; Lim YA; Lee WG; Park JS; Kim HC; Lee HJ; Cho SR
Cancer Genet Cytogenet; 2008 Sep; 185(2):106-8. PubMed ID: 18722880
[TBL] [Abstract][Full Text] [Related]
14. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
Martinelli G; Testoni N; Montefusco V; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazzi F; de Vivo A; Pane F; Rosti G; Tura S
Haematologica; 1998 Jul; 83(7):593-601. PubMed ID: 9718863
[TBL] [Abstract][Full Text] [Related]
15. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
[TBL] [Abstract][Full Text] [Related]
16. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.
Amabile M; Giannini B; Testoni N; Montefusco V; Rosti G; Zardini C; Terragna C; Buonamici S; Ottaviani E; Soverini S; Fiacchini M; Bassi S; de Vivo A; Trabacchi E; Saglio G; Pane F; Baccarani M; Tura S; Martinelli G
Haematologica; 2001 Mar; 86(3):252-9. PubMed ID: 11255271
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia].
Rosas-Cabral A; Martínez-Mancilla M; Ayala-Sánchez M; Vela-Ojeda J; Bahena-Reséndiz P; Vadillo-Buenfil M; Aviña-Zubieta JA; Salazar-Exaire D; Miranda-Peralta E; Marroquín A; Longoria-Revilla E
Gac Med Mex; 2003; 139(6):553-9. PubMed ID: 14723051
[TBL] [Abstract][Full Text] [Related]
18. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction].
Luo Z; Chen H; Luo S; Tang L; Wang J
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671
[TBL] [Abstract][Full Text] [Related]
19. Long-template DNA polymerase chain reaction for the detection of the bcr/abl translocation in patients with chronic myelogenous leukemia.
Waller CF; Dennebaum G; Feldmann C; Lange W
Clin Cancer Res; 1999 Dec; 5(12):4146-51. PubMed ID: 10632353
[TBL] [Abstract][Full Text] [Related]
20. Differential molecular response of the transcripts B2A2 and B3A2 to imatinib mesylate in chronic myeloid leukemia.
de Lemos JA; de Oliveira CM; Scerni AC; Bentes AQ; Beltrão AC; Bentes IR; Azevedo TC; Maradei-Pereira LM
Genet Mol Res; 2005 Dec; 4(4):803-11. PubMed ID: 16475128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
